GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » Interest Coverage

Charmacy Pharmaceutical Co (HKSE:02289) Interest Coverage : 2.23 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Charmacy Pharmaceutical Co's Operating Income for the six months ended in Dec. 2024 was HK$66 Mil. Charmacy Pharmaceutical Co's Interest Expense for the six months ended in Dec. 2024 was HK$-29 Mil. Charmacy Pharmaceutical Co's interest coverage for the quarter that ended in Dec. 2024 was 2.23. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Charmacy Pharmaceutical Co's Interest Coverage or its related term are showing as below:

HKSE:02289' s Interest Coverage Range Over the Past 10 Years
Min: 1.88   Med: 2.96   Max: 5.29
Current: 2.3


HKSE:02289's Interest Coverage is ranked worse than
81.52% of 92 companies
in the Medical Distribution industry
Industry Median: 7.18 vs HKSE:02289: 2.30

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Charmacy Pharmaceutical Co Interest Coverage Historical Data

The historical data trend for Charmacy Pharmaceutical Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Charmacy Pharmaceutical Co Interest Coverage Chart

Charmacy Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.32 1.88 2.86 2.81 2.30

Charmacy Pharmaceutical Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.98 3.40 2.40 2.36 2.23

Competitive Comparison of Charmacy Pharmaceutical Co's Interest Coverage

For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charmacy Pharmaceutical Co's Interest Coverage Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Charmacy Pharmaceutical Co's Interest Coverage falls into.


;
;

Charmacy Pharmaceutical Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Charmacy Pharmaceutical Co's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Charmacy Pharmaceutical Co's Interest Expense was HK$-65 Mil. Its Operating Income was HK$149 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$52 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2024 )/Interest Expense (A: Dec. 2024 )
=-1*148.938/-64.756
=2.30

Charmacy Pharmaceutical Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the six months ended in Dec. 2024, Charmacy Pharmaceutical Co's Interest Expense was HK$-29 Mil. Its Operating Income was HK$66 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$52 Mil.

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*65.598/-29.414
=2.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Charmacy Pharmaceutical Co  (HKSE:02289) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Charmacy Pharmaceutical Co Interest Coverage Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Charmacy Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041
Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes Western medicine, Chinese patent medicine, and healthcare products to downstream distributors and retail terminals while conducting dealings in the third-party logistics business of medicines and providing pharmaceutical products-related consulting services. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
Executives
Jiangxi Pharmaceutical Investment Co., Limited 2101 Beneficial owner
Jiang Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Jiang Xi Jiang Zhong Yi Yao Shang Ye Yun Ying You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Yao Chuanglong 2101 Beneficial owner
You Zeyan 2202 Interest of your spouse
Guang Zhou Bai Yun Shan Yi Yao Ji Tuan Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Zhou Yi Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Yao Bai Yun Shan Xiang Gang You Xian Gong Si 2101 Beneficial owner
Rays Capital Partners Limited 2102 Investment manager
Ruan David Ching Chi 2201 Interest of corporation controlled by you
Asian Equity Special Opportunities Portfolio Master Fund Limited 2101 Beneficial owner
Wang Yonghui 2101 Beneficial owner

Charmacy Pharmaceutical Co Headlines

No Headlines